Related Experiment Videos
Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation.
P G Kasprzyk1, F Cuttitta, I Avis
1National Cancer Institute-Navy Medical Oncology Branch, Bethesda, Maryland 20814.
Analytical Biochemistry
|October 1, 1988
Summary
A novel radioimmunoassay uses labeled antibodies instead of labeled peptides for rapid, sensitive peptide hormone quantification. This method enhances accuracy and efficiency in detecting peptide levels.
Area of Science:
- Biochemistry
- Immunology
- Assay Development
Background:
- Traditional peptide quantitation assays often face sensitivity issues due to oxidant damage during radioactive labeling.
- Existing methods for peptide hormone measurement can be time-consuming and less efficient.
Purpose of the Study:
- To develop a modified solid-phase radioimmunoassay for sensitive and rapid peptide hormone quantitation.
- To validate a novel detection system using iodinated peptide-specific monoclonal antibodies.
Main Methods:
- Development of a radioimmunoassay employing iodinated monoclonal antibodies as the detection system.
- Optimization of radioactive labeling conditions to minimize oxidant damage.
- Use of glutaraldehyde pretreatment for enhanced peptide retention and antibody binding on solid-phase microplates.
Main Results:
- The modified assay demonstrated rapid quantitation, completed within 1 hour of peptide solid phasing.
- Glutaraldehyde pretreatment significantly improved peptide binding and antibody accessibility, optimizing antigen presentation.
- Quantitation of gastrin-releasing peptide in samples showed strong agreement with previously reported techniques.
Conclusions:
- A modified microplate assay enables rapid and sensitive quantitation of peptide hormones.
- The use of iodinated monoclonal antibodies offers a robust alternative detection system.
- This assay has broad applicability for precise peptide hormone measurement.